research use only

Zenidolol (ICI-118551) Hydrochloride Adrenergic Receptor antagonist

Cat.No.S8114

Zenidolol (ICI-118551) Hydrochloride is a highly selective β2-adrenergic receptor antagonist with Ki values of 0.7, 49.5 and 611 nM for β2, β1 and β3 receptors, respectively.
Zenidolol (ICI-118551) Hydrochloride Adrenergic Receptor antagonist Chemical Structure

Chemical Structure

Molecular Weight: 313.86

Jump to

Quality Control

Batch: Purity: 99.45%
99.45

Cell Culture, Treatment & Working Concentration

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
CHO Function assay 120 mins Displacement of [3H]CGP 12177 from human recombinant beta2 adrenergic receptor expressed in CHO cells measured after 120 mins by scintillation counting method, IC50=0.00074μM 27876250
CHOK1 Function assay 2 hrs Displacement of [3H](-)CGP12177 from human beta2-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method, Kd=0.0002455μM 28523097
CHOK1 Function assay 2 hrs Displacement of [3H](-)CGP12177 from human beta1-AR expressed in CHOK1 cells after 2 hrs by TopCount microscintillation counting method, Kd=0.18197μM 28523097
Click to View More Cell Line Experimental Data

Solubility

In vitro
Batch:

DMSO : 62 mg/mL (197.54 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 62 mg/mL

Water : 21 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 313.86 Formula

C17H27NO2.HCl

Storage (From the date of receipt)
CAS No. 72795-01-8 Download SDF Storage of Stock Solutions

Synonyms ICI-118,551 Smiles CC1=C2CCCC2=C(C=C1)OCC(C(C)NC(C)C)O.Cl

Mechanism of Action

Targets/IC50/Ki
β2-adrenergic receptor
(Cell-free assay)
0.7nM(Ki)
β1-adrenergic receptor
(Cell-free assay)
49.5nM(Ki)
β3-adrenoceptor
(Cell-free assay)
611nM(Ki)
In vitro

ICI-118551 inhibits cAMP accumulation by 50% (IC50 = 1.7 mM).  ICI 118551 increases vascular lumen diameter in lung sections and reduces pulmonary arterial pressure under normoxia and under hypoxia in the isolated perfused lung model. Transgenic mice with high beta(2)AR number and increased G(i) levels have normal basal contractility but show a similar negative inotropic response to ICI 118,551. Overexpression of human beta(2)AR in rabbit myocytes using adenovirus potentiates the negative inotropic effect of ICI 118,551. In human, rabbit, and mouse myocytes, the negative inotropic effects are blocked after treatment of cells with pertussis toxin to inactivate G(i), and overexpression of G(i)alpha(2) induces the effect de novo in normal rat myocytes.

In vivo

After 1 week of treatment, ICI 118,551 has no effect on the beta 1-receptor mediated shortening of electromechanical systole (QS2I), the rise in systolic pressure and rise in renin, whereas these responses are blocked by a dose factor of eight. ICI 118,551 and equally block the beta 2-receptor mediated fall in diastolic pressure and the rise in noradrenaline. beta 2-selective blockade by ICI 118,551 lowers blood pressure.

References
  • [4] https://pubmed.ncbi.nlm.nih.gov/2908820/
  • [5] https://pubmed.ncbi.nlm.nih.gov/12034656/
  • [6] https://pubmed.ncbi.nlm.nih.gov/24340001/

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map